Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 14, 2017

Total Value ($000): $835,774 (99.2% shares, 0.8% debt)

Holdings (21)

INGN INOGEN INC 40.5%

Value ($000) $338,676 Shares 3,549,320 Est. Cost $17.78 Unrealized +380.7%

ANAB ANAPTYSBIO INC 8.7%

Value ($000) $72,592 Shares 3,033,504 Est. Cost $23.32 Unrealized +7.8%

— ACCELERON PHARMA INC 5.7%

Value ($000) $47,224 Shares 1,553,937 Est. Cost $27.65 Unrealized —

— SPECTRANETICS CORP 5.5%

Value ($000) $45,616 Shares 1,187,917 Est. Cost $18.19 Unrealized —

— DERMIRA INC 5.4%

Value ($000) $44,720 Shares 1,534,664 Est. Cost $31.03 Unrealized —

CRVS CORVUS PHARMACEUTICALS INC 4.7%

Value ($000) $39,253 Shares 3,244,046 Est. Cost $14.33 Unrealized -25.5%

— RA PHARMACEUTICALS INC 4.6%

Value ($000) $38,071 Shares 2,031,562 Est. Cost $15.19 Unrealized —

— FLEXION THERAPEUTICS INC 3.6%

Value ($000) $30,330 Shares 1,500,000 Est. Cost $16.59 Unrealized —

AKBA AKEBIA THERAPEUTICS INC 3.1%

Value ($000) $26,071 Shares 1,814,289 Est. Cost $10.63 Unrealized +19.2%

— NABRIVA THERAPEUTICS PLC 2.9%

Value ($000) $24,382 Shares 2,326,544 Est. Cost $10.48 Unrealized —

— OBSEVA SA 2.8%

Value ($000) $23,177 Shares 2,710,760 Est. Cost $10.41 Unrealized —

— MERUS N V 2.7%

Value ($000) $22,355 Shares 1,410,417 Est. Cost $7.99 Unrealized —

KALV KALVISTA PHARMACEUTICALS INC 2.6%

Value ($000) $21,358 Shares 2,901,927 Est. Cost $7.37 Unrealized -0.3%

— REATA PHARMACEUTICALS INC 2.2%

Value ($000) $18,756 Shares 592,794 Est. Cost $19.75 Unrealized —

— APOLLO ENDOSURGERY INC 1.3%

Value ($000) $10,667 Shares 1,351,972 Est. Cost $12.16 Unrealized —

— INVUITY INC 1.2%

Value ($000) $9,888 Shares 1,363,848 Est. Cost $9.51 Unrealized —

— VERONA PHARMA PLC 1.0%

Value ($000) $8,637 Shares 740,740 Est. Cost $11.66 Unrealized —

— WRIGHT MED GROUP N V 0.8%

Value ($000) $6,748 Shares 4,622,032 Est. Cost $1.25 Unrealized —

CRSP CRISPR THERAPEUTICS AG 0.4%

Value ($000) $3,578 Shares 223,317 Est. Cost $18.69 Unrealized -11.6%

— HTG MOLECULAR DIAGNOSTICS INC 0.4%

Value ($000) $3,273 Shares 1,230,399 Est. Cost $11.15 Unrealized —

XENE XENON PHARMACEUTICALS INC 0.0%

Value ($000) $402 Shares 127,563 Est. Cost $14.68 Unrealized -73.4%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
INGN	INOGEN INC	3,549,320	$338,676	40.5%	$17.78	+380.7%	COM	45780L104
ANAB	ANAPTYSBIO INC	3,033,504	$72,592	8.7%	$23.32	+7.8%	COM	032724106
—	ACCELERON PHARMA INC	1,553,937	$47,224	5.7%	$27.65	—	COM	00434H108
—	SPECTRANETICS CORP	1,187,917	$45,616	5.5%	$18.19	—	COM	84760C107
—	DERMIRA INC	1,534,664	$44,720	5.4%	$31.03	—	COM	24983L104
CRVS	CORVUS PHARMACEUTICALS INC	3,244,046	$39,253	4.7%	$14.33	-25.5%	COM	221015100
—	RA PHARMACEUTICALS INC	2,031,562	$38,071	4.6%	$15.19	—	COM	74933V108
—	FLEXION THERAPEUTICS INC	1,500,000	$30,330	3.6%	$16.59	—	COM	33938J106
AKBA	AKEBIA THERAPEUTICS INC	1,814,289	$26,071	3.1%	$10.63	+19.2%	COM	00972D105
—	NABRIVA THERAPEUTICS PLC	2,326,544	$24,382	2.9%	$10.48	—	SHS	G63637105
—	OBSEVA SA	2,710,760	$23,177	2.8%	$10.41	—	COM	H5861P103
—	MERUS N V	1,410,417	$22,355	2.7%	$7.99	—	COM	N5749R100
KALV	KALVISTA PHARMACEUTICALS INC	2,901,927	$21,358	2.6%	$7.37	-0.3%	COM	483497103
—	REATA PHARMACEUTICALS INC	592,794	$18,756	2.2%	$19.75	—	CL A	75615P103
—	APOLLO ENDOSURGERY INC	1,351,972	$10,667	1.3%	$12.16	—	COM	03767D108
—	INVUITY INC	1,363,848	$9,888	1.2%	$9.51	—	COM NEW	46187J205
—	VERONA PHARMA PLC	740,740	$8,637	1.0%	$11.66	—	SPONSORED ADS	925050106
—	WRIGHT MED GROUP N V	4,622,032	$6,748	0.8%	$1.25	—	RIGHT 03/01/2019	N96617126
CRSP	CRISPR THERAPEUTICS AG	223,317	$3,578	0.4%	$18.69	-11.6%	NAMEN AKT	H17182108
—	HTG MOLECULAR DIAGNOSTICS INC	1,230,399	$3,273	0.4%	$11.15	—	COM	40434H104
XENE	XENON PHARMACEUTICALS INC	127,563	$402	0.0%	$14.68	-73.4%	COM	98420N105